Market Research Report
Electrophysiology Ablation Catheters (Cardiovascular Devices) - Global Market Analysis and Forecast Model
|Published by||GlobalData||Product code||646129|
Delivery time: 1-2 business days
|Electrophysiology Ablation Catheters (Cardiovascular Devices) - Global Market Analysis and Forecast Model|
|Published: December 3, 2018||Content info:||
Electrophysiology Ablation Catheters (Cardiovascular Devices) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
Electrophysiology Ablation is applicable for a wide variety of arrhythmias and has an extremely high success rate with low rates of complication and recurrence. Arrhythmia is a condition of the heart in which the heart is either beating too fast, too slow or with an irregular rhythm. Conventional RF ablation catheters are used with RF generator to supply remedial, heat-based energy at a targeted space of cardiac tissue. RF energy, released through the catheter, destroys tissues which are involved in onset and maintenance of most atrial tachyarrhythmias. One unit refers to one conventional RF ablation catheter.
A cryoablation catheter consists of a thin, long versatile tube that transports pressurized refrigerant (cold liquid) to a particular location within the heart to treat cardiac arrhythmias. Cooling of the catheter tip throughout RF ablation is achieved by current saline through or round the tip of ablation catheter where RF current is being delivered. The catheter is irrigated outwardly and cooler temperature is maintained. The catheter machine-controlled power management provides temperature monitoring and creates larger lesions with lesser power consumption. Laser ablation catheters utilize a direct laser to perform the ablation.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Biosense Webster Inc, Abbott Laboratories, Boston Scientific Corp, Medtronic plc, CardioFocus Inc, Biotronik AG, Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -